1Genc S, Koroglu T F, Genc K. Erythropoietin and the nervous system [ J ]. Brain Res, 2004,1000 ( 1-2 ) : 19-31.
2Grasso G, Sfacteria A, Passalacqua M, et al. Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin [ J ]. Neurosurgery, 2005,56 ( 4 ) : 821-827.
3Campana W M, Myers R R. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury[J]. FASEB J,2001,15 (10) :1804-1806.
4Li X,Gonias S L,Campana W M. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury [ J ]. Glia,2005,51 ( 4 ) :254-265.
5Genc S,Koroglu T F,Genc K. Erythropoietin as a novel neuroprotectant[ J]. Restor Neurol Neurosci ,2004,22 ( 2 ) : 105- 119.
6Claudia Bartels, Kira Spate, Henning Krampe, et al. Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis[ J ]. Therapeutic Advances in Neurological Disorders, 2008, 1: 193-206.
7Jelkmann W. Molecular biology of erythropoietin[ J]. Internal Medicine ,2004,43 ( 8 ) :649-659.
8Lappin T. The cellular biology of erythropoietin receptors [ J ]. The Oncologist ,2003,8( suppl1) :15-18.
9Digicaylioglu M, Lipton S A. Erythropoietin mediated neuroprotection involves cross talk between Jak2 and NF- κβsignaling cascades [ J ]. Nature, 2001,412 ( 6847 ) : 641 - 647.
10Celik M, Gokmen N, Erbayraktar S, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury[J]. Proc Natl Acad Sci USA ,2002,99(4) :2258-2263.
2Li J,Dowdy S,Tipton T,et al.HE4 as a biomarker for ovarian and endometrial cancer management[J].Expert Rev Mol Diagn,2009,9(6):555-566.
3Erkan kaptanoglu,Ihsan Solaroglu,Ozerk Okutan,et al.Erythropoietin exerts neuroprotection after acute spinal cord injury in rats:effect on lipid peroxidation and early ultra-structural findings[J].Neurosurgical Review,2004,27(2):113-120.
4Wani MC,Taylor HL,Wall ME,et al.Plant antitumor a-gents VI isolation and structure of taxol,a novel antileukemic and antitumor agent from Taxus brevifolia[J].J Am Chem Soc,1971,93(9):2325-2327.
5Shimozuma K,Ohashi Y,Takeuchi A,et al.Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy:N-SAS BC 02,a randomized clinical trial[J].Support Care Cancer,2012,20(12):3355-3364.
6Beijers AJ,Jongen JL,Vreugdenhil G.Chemotherapy-induced neurotoxicity:the value of neuroprotective strategies[J].Neth J Med,2012,70(1):18-25.
7Kothari R,Nagel C,Koopmeiners JS,et al.The effect of age on the tolerability of intraperitoneal chemotherapy,complication rate,and surviral in patients with ovarian cancer[J].Gynecol Oncol,2010,119(3);491-495.
